Similar articles for PMID: 25744864

Year	Number of Results
1978	1
1995	1
1996	2
1997	5
1998	1
1999	1
2000	2
2001	2
2002	3
2003	4
2004	8
2005	7
2006	3
2007	5
2008	6
2009	6
2010	3
2011	4
2012	3
2013	9
2014	2
2015	3
2016	2
2017	2
2018	2
2020	4
2021	1
2023	1
2024	0

1

Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.

Gambini D, Visintin R, Locatelli E, Bareggi C, Galassi B, Runza L, Blundo C, Sosnovskikh I, Tomirotti M. Gambini D, et al. Tumori. 2015 Apr 28;101(2):e60-3. doi: 10.5301/tj.5000252. Tumori. 2015. PMID: 25744864 Review.

2

Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma.

Gambini D, Visintin R, Locatelli E, Galassi B, Bareggi C, Runza L, Onida F, Tomirotti M. Gambini D, et al. Tumori. 2009 Nov-Dec;95(6):828-31. doi: 10.1177/030089160909500631. Tumori. 2009. PMID: 20210253

3

Response to paclitaxel in a radiotherapy-induced breast angiosarcoma.

Perez-Ruiz E, Ribelles N, Sanchez-Muñoz A, Roman A, Marquez A. Perez-Ruiz E, et al. Acta Oncol. 2009;48(7):1078-9. doi: 10.1080/02841860902777115. Acta Oncol. 2009. PMID: 19235566 No abstract available.

4

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PC, Marreaud S, Van Glabbeke M, Blay JY. Schlemmer M, et al. Eur J Cancer. 2008 Nov;44(16):2433-6. doi: 10.1016/j.ejca.2008.07.037. Epub 2008 Sep 2. Eur J Cancer. 2008. PMID: 18771914

5

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY. Penel N, et al. J Clin Oncol. 2008 Nov 10;26(32):5269-74. doi: 10.1200/JCO.2008.17.3146. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809609 Clinical Trial.

6

Angiosarcoma of the breast: a difficult surgical challenge.

Hui A, Henderson M, Speakman D, Skandarajah A. Hui A, et al. Breast. 2012 Aug;21(4):584-9. doi: 10.1016/j.breast.2012.01.001. Epub 2012 Feb 3. Breast. 2012. PMID: 22305554 Free article.

7

Salvage weekly paclitaxel in recurrent ovarian cancer.

Abu-Rustum NR, Aghajanian C, Barakat RR, Fennelly D, Shapiro F, Spriggs D. Abu-Rustum NR, et al. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-62-S15-67. Semin Oncol. 1997. PMID: 9346225 Clinical Trial.

8

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

9

Angiosarcoma associated with a Kasabach-Merritt syndrome: report of two cases treated with paclitaxel.

Grellety T, Italiano A. Grellety T, et al. Future Oncol. 2013 Sep;9(9):1397-9. doi: 10.2217/fon.13.109. Future Oncol. 2013. PMID: 23980686

10

Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy.

Mano MS, Fraser G, Kerr J, Gray M, Evans V, Kazmi A, Canney P. Mano MS, et al. Breast. 2006 Feb;15(1):117-8. doi: 10.1016/j.breast.2004.10.007. Epub 2004 Dec 25. Breast. 2006. PMID: 16473744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year